# Ranked Hypotheses -- Cycle 1
# Session: 2026-03-18-targeted-001
# Fields: Ferroptosis biology x Bacterial quorum sensing biochemistry
# Ranker: Sonnet 4.6 | Date: 2026-03-18
# Surviving hypotheses scored: 5 (H1 WOUNDED, H2 SURVIVES, H5 WOUNDED, H7 WOUNDED, H8 SURVIVES)

---

## Per-Hypothesis Scoring Tables

---

### Hypothesis H1: 4-HNE as a Cross-Kingdom Quorum Sensing Mimic that Activates LuxR Solo Receptors in Gut Commensals

**Critic verdict**: WOUNDED | Revised confidence: 3/10
**Key weakness**: Lactone ring required for all known LuxR activation; 4-HNE t1/2 < 2 min in biological milieu; no ring-free LuxR activator known; mucus barrier blocks diffusion

| Dimension | Weight | Score (1-10) | Justification |
|-----------|--------|-------------|---------------|
| Novelty | 20% | 8 | The Critic performed direct searches for "4-HNE structure quorum sensing AHL mimic bacterial receptor" and "isoprostanes LuxR binding quorum sensing lipid peroxidation bacterial" and found zero papers connecting 4-HNE to any LuxR-family receptor activation. The ferroptosis-to-QS direction (host lipid peroxidation products affecting bacterial signaling) remains entirely unexplored, as confirmed by the absence of literature in this directional space -- distinct from the 2025 Nature Comms PQS-to-ferroptosis paper which runs in the opposite direction. The Critic explicitly confirmed novelty holds for this specific directional claim. |
| Mechanistic Specificity | 20% | 4 | The hypothesis names specific molecules (4-HNE, SdiA, LuxR solo receptors, the alpha,beta-unsaturated carbonyl motif) and references concentration ranges (0.1-5 uM 4-HNE ferroptotic release, 1-5 nM SdiA activation threshold). However, the only quantitative mechanistic claim -- that the lactone ring contributes "~30% of total binding energy" -- was found by the Critic to be unverifiable and likely an underestimate, with the TraR crystal structure showing the ring makes three direct H-bonds to Trp57, Tyr53, and Asp70. No docking data or binding affinity for a ring-free ligand in any LuxR pocket has been published, leaving the core binding claim at the level of structural analogy rather than quantified mechanism. |
| Cross-field Distance | 10% | 8 | Ferroptosis lipid biochemistry and bacterial quorum sensing are deeply disjoint disciplines with distinct research communities, model organisms, journals, and conceptual frameworks. The bridge spans lipid oxidation chemistry, inter-kingdom chemical ecology, and microbial receptor biology -- subfields that essentially never interact. The Critic confirmed these fields were assessed as DISJOINT at the session outset. |
| Testability | 20% | 8 | Testable within a standard 3-month PhD rotation: purify SdiA (or use the established SdiA-GFP reporter in E. coli), measure binding by fluorescence thermal shift or ITC with 4-HNE across a concentration range (1 nM to 100 uM), confirm functional activity with a QS reporter assay. The Critic explicitly confirmed this passes the falsifiability test. A clear negative result (no binding, no reporter activation) would decisively kill the hypothesis; a positive would launch a new field. No specialized equipment or novel techniques are required. |
| Impact | 10% | 6 | If confirmed, the finding would establish a class of host-derived eukaryotic lipid peroxidation products as inter-kingdom signaling molecules capable of activating bacterial gene regulation, redirecting ferroptosis research toward microbiome ecology and potentially identifying a host-microbiome immune axis. Impact is bounded by the severe structural problems (no ring-free LuxR activator known), suggesting the finding, if real, would be a narrow exception to LuxR pharmacology rather than a new paradigm -- the field would debate mechanism rather than accept a new framework immediately. |
| Groundedness | 20% | 3 | The Critic assessed groundedness at ~50% but the critical load-bearing claims are ungrounded. The "~30% binding energy" claim is unverifiable and likely wrong (the Critic identified three direct H-bonds to the ring, suggesting the ring contribution is higher). The claim that 4-HNE fits a LuxR pocket is purely speculative with no computational or experimental data. The verified counter-evidence -- 4-HNE t1/2 < 2 min in biological milieu, the mucus barrier (50-800 um), all known SdiA activators retaining a ring moiety, AHL-lactonase specificity for ring-containing substrates -- represents active evidence against the mechanism. The score of 3 reflects that while peripheral facts (4-HNE structure, SdiA promiscuity existence) are real, the core mechanistic connection is ungrounded and the only quantitative claim appears wrong. |
| **Composite** | | **5.50** | (8x0.20)+(4x0.20)+(8x0.10)+(8x0.20)+(6x0.10)+(3x0.20) = 1.60+0.80+0.80+1.60+0.60+0.60 |

---

### Hypothesis H2: Ferroptotic Iron Release Creates Localized Siderophore-Independent Iron Bonanza Triggering QS Threshold Collapse in P. aeruginosa

**Critic verdict**: SURVIVES | Revised confidence: 4/10
**Key weakness**: LIP may not expand during ferroptosis (2025 bioRxiv); Fur represses virulence under iron excess; field converging rapidly (2025 Nature Comms PQS paper)

| Dimension | Weight | Score (1-10) | Justification |
|-----------|--------|-------------|---------------|
| Novelty | 20% | 5 | The Critic identified multiple 2024-2025 papers actively exploring adjacent territory: a 2025 Nature Communications paper (PQS induces macrophage ferroptosis), a 2025 Virulence review (ferroptosis in P. aeruginosa infections), and a 2024 Advanced Science paper (bacterial siderophore pyoverdine drives ferroptosis resistance in tumors). The ferroptosis-iron-Pseudomonas nexus is now an active research area. The specific "QS threshold collapse" model -- ferroptotic iron release lowering the cell-density activation threshold -- has not been published, preserving partial novelty. However, the broader conceptual connection is rapidly becoming obvious to the field, and the novelty window is closing. Score reflects partial novelty degradation from field convergence. |
| Mechanistic Specificity | 20% | 5 | The hypothesis names specific regulatory components: labile iron pool, ferritin (~4,500 Fe atoms/cage), siderophore bypass, Fur/PvdS/PQS regulatory axes, and per-cell AHL overproduction as the QS accelerant. However, critical quantitative steps are unspecified: how much iron is released extracellularly per ferroptotic cell, on what timescale, how this compares to the nutritional immunity response (lactoferrin, lipocalin-2, calprotectin acting in minutes), and what per-cell AHL increase is needed to lower the QS activation threshold by the proposed amount. The mechanism is named but not quantified at the steps that matter most. |
| Cross-field Distance | 10% | 7 | Ferroptosis biology and P. aeruginosa QS biochemistry are distinct fields, though both participate in infection biology -- they share iron as a conceptual currency. The bridge via iron-mediated QS modulation is a conceptually adjacent move within the infection biology space, somewhat reducing cross-field distance compared to more exotic hypotheses. Still, the fields do not typically interact, and combining ferroptosis cell death dynamics with QS regulatory thresholds is a genuine cross-field synthesis. |
| Testability | 20% | 7 | Testable in a co-culture system: induce ferroptosis in a mammalian cell line (RSL3 or GPX4 inhibitor treatment) co-cultured with P. aeruginosa PAO1::lasB-gfp QS reporter, with deferoxamine iron chelator controls and ferrostatin-1 ferroptosis rescue controls. The Critic confirmed this passes the falsifiability test. The timescale mismatch (ferroptotic iron release in minutes vs QS dynamics over hours) is a genuine experimental challenge but tractable by adjusting cell death timing relative to bacterial inoculation. Within a motivated 3-month effort by a PhD student with cell biology and microbiology expertise. |
| Impact | 10% | 6 | If confirmed, this would provide a mechanistic explanation for why P. aeruginosa virulence escalates at sites of host cell death, with potential implications for anti-virulence strategies combining ferroptosis inhibitors with antibiotic therapy. The impact is bounded by the rapidly converging field -- by the time this is validated, other groups may have established the ferroptosis-P.aeruginosa iron axis through different angles. It would add mechanistic depth rather than opening a new field. |
| Groundedness | 20% | 4 | The Critic assessed groundedness at ~55% but with significant qualifications. Two load-bearing claims are actively contradicted: (1) the 2025 bioRxiv finding that the labile iron pool does NOT measurably expand during ferroptosis induction directly undermines the core premise; (2) Fur-mediated repression of PvdS and PrrF sRNAs under iron-replete conditions (verified) means the "iron bonanza" may paradoxically suppress some virulence genes, contradicting the simple "more iron = more virulence" model. The grounded facts (ferritin iron content, P. aeruginosa iron systems, PQS-iron interaction) are peripheral to the core mechanism. Score of 4 reflects two verified contradictions against the hypothesis's central claims. |
| **Composite** | | **5.50** | (5x0.20)+(5x0.20)+(7x0.10)+(7x0.20)+(6x0.10)+(4x0.20) = 1.00+1.00+0.70+1.40+0.60+0.80 |

---

### Hypothesis H5: Bacterial AHL Lactonases Inadvertently Degrade 4-HNE Cyclic Derivatives as Microbial Detoxification Service

**Critic verdict**: WOUNDED | Revised confidence: 2/10
**Key weakness**: 4-HNE cyclization produces cyclic ethers (tetrahydrofuran), not lactones; AHL lactonases hydrolyze ester bonds in lactone rings; cyclic ethers have no ester bond; chemical error in mechanism

| Dimension | Weight | Score (1-10) | Justification |
|-----------|--------|-------------|---------------|
| Novelty | 20% | 7 | The Critic found no published work connecting AHL lactonases to 4-HNE or any ferroptosis-derived lipid products. The PON-lactonase evolutionary relationship is documented (Draganov et al. 2005) but the specific inter-kingdom detoxification framing -- gut bacteria providing a "service" by degrading host-derived ferroptotic lipid products via quorum-quenching enzymes -- has not been assembled in any published work. Novelty holds but is constrained by the fact that the mechanism requires a chemical step (cyclic ether hydrolysis by an esterase) that does not occur, making the novelty partly an artifact of chemical error rather than genuine unexplored territory. |
| Mechanistic Specificity | 20% | 3 | The hypothesis names specific enzymes (AiiA, PON-family lactonases), a specific proposed substrate chemistry (4-HNE cyclization products), and identifies the evolutionary relationship between mammalian PONs and bacterial lactonases. However, the Critic identified a fundamental chemical error: 4-HNE cyclizes to form tetrahydrofuran (cyclic ether) derivatives, not lactones. AHL lactonases catalyze ester bond hydrolysis in lactone rings -- a cyclic ether contains no ester bond and is not a substrate for this enzyme class. The mechanism names the right enzyme family and asks the right evolutionary question but has misidentified the substrate chemistry at the central reaction step. |
| Cross-field Distance | 10% | 7 | The hypothesis bridges host cell ferroptosis lipid biochemistry, bacterial enzyme promiscuity, and inter-kingdom detoxification ecology. These are distinct subfields. The specific enzymatic cross-reactivity framing adds a microbial ecology and enzyme evolution dimension that is further from standard ferroptosis biology than a straightforward QS signaling hypothesis, pushing cross-field distance above the median for this hypothesis set. |
| Testability | 20% | 9 | This is the most directly and immediately testable surviving hypothesis. The Critic confirmed: purify AiiA (or any characterized AHL lactonase), incubate with 4-HNE and its cyclization products, measure hydrolysis by LC-MS or the standard Ellman assay adapted for alcohol release. This can be completed by a biochemist in days to weeks, requires no specialized equipment, and produces an unambiguous positive or negative result. Even the expected negative result (no hydrolysis, consistent with the cyclic ether problem identified by the Critic) would be an informative, publishable negative that clarifies enzyme substrate scope. |
| Impact | 10% | 5 | If AHL lactonases genuinely metabolize ferroptotic lipid products (whether via the proposed cyclic ether route or a corrected lactone-forming pathway), this would establish a new "microbiome detoxification service" model for gut health, with implications for probiotic engineering and gut-lipid-disease crosstalk. Impact is bounded because (1) the chemical mechanism is likely wrong as stated, requiring salvage via a different 4-HNE oxidation product that actually forms a lactone ring, and (2) host GST and ALDH pathways would likely dominate 4-HNE clearance, making microbial contribution marginal. |
| Groundedness | 20% | 3 | The Critic assessed groundedness at ~40% and identified a chemical error in the core mechanism. Grounded facts include the PON-lactonase evolutionary relationship (Draganov et al. 2005), AHL lactonase substrate specificity data (Wang et al. 2004 JBC -- which is actually counter-evidence: "no or little residue activity to non-acyl lactones and noncyclic esters"), and the dominance of GST/ALDH in mammalian 4-HNE detoxification. The central substrate claim (4-HNE forms lactone-like products that AHL lactonases can hydrolyze) is chemically wrong as stated. The Bacillus AiiA homolog presence in gut microbiome is parametric and unverified. Score of 3 reflects a verified chemical error at the mechanistic core alongside grounded peripheral facts. |
| **Composite** | | **5.60** | (7x0.20)+(3x0.20)+(7x0.10)+(9x0.20)+(5x0.10)+(3x0.20) = 1.40+0.60+0.70+1.80+0.50+0.60 |

---

### Hypothesis H7: ACSL4 Ferroptosis Sensitivity Under Balancing Selection from Pathogen QS-Triggered Iron Theft

**Critic verdict**: WOUNDED | Revised confidence: 3/10
**Key weakness**: Brain function selection pressure on ACSL4 likely dwarfs infection-driven selection; multi-link causal chain with confounders; signal may be statistically undetectable

| Dimension | Weight | Score (1-10) | Justification |
|-----------|--------|-------------|---------------|
| Novelty | 20% | 8 | The Critic searched "ACSL4 population genetics selection pressure variants human" and found no published work applying population genomic selection analysis to ACSL4 in the context of ferroptosis or infection. The closest work concerns ACSL1 (not ACSL4) in dietary lipid selection. Combining evolutionary population genomics with the ferroptosis-QS interface is a genuinely unexplored synthesis. The Critic rated this as LOW hallucination-as-novelty risk: the novelty arises from real synthesis of independently verified facts (ACSL4 biology, ExoU activity, evolutionary selection framework), not from fabricated properties. |
| Mechanistic Specificity | 20% | 4 | The hypothesis names specific components: ACSL4's PUFA phospholipid synthesis role, ExoU phospholipase activity exploiting host lipid peroxidation (verified, PLoS Pathogens 2021), iron theft via siderophores, ferroptosis as the specific death mode, and balancing selection as the evolutionary outcome. However, no quantitative estimate of selection coefficient magnitude is provided, no specific ACSL4 variant or haplotype is identified as the predicted target of selection, no genomic signal type is specified (FST, Tajima's D, iHS), and the four-link causal chain (QS activates virulence -> virulence includes ExoU + iron theft -> these trigger ferroptosis -> ferroptosis selects on ACSL4) lacks quantitative grounding at each step. |
| Cross-field Distance | 10% | 9 | This hypothesis spans the greatest conceptual distance in the surviving set: bacterial quorum sensing biochemistry to molecular evolutionary genetics and human population genomics, bridged through ferroptosis cell biology. These three communities essentially never interact. A QS researcher does not read population genetics; a population genomicist working on selection has no reason to know about lactonase biochemistry. The cross-field synthesis is genuinely bold and the distance is the highest among all survivors. |
| Testability | 20% | 5 | Technically testable: a PhD student could analyze existing population genomic datasets (1000 Genomes, gnomAD, ancient DNA repositories) for ACSL4 selection signatures in 3 months of computational work. However, the Critic identified a serious statistical power problem: brain function selection pressure on ACSL4 (association with non-syndromic intellectual disability, dendritic spine formation, neural development) likely dwarfs any infection-driven signal. Additionally, only ~30% of P. aeruginosa strains express ExoU, making the selection pressure inconsistent across encounters. The analysis is feasible but interpreting any signal would require controlling for confounders that may be impossible to disentangle from the available data. |
| Impact | 10% | 7 | If true, this would be one of very few documented examples of a specific regulated cell death pathway gene under pathogen-driven balancing selection, creating a new paradigm for how host cell death machinery co-evolves with microbial virulence strategies. The evolutionary genomics angle is sufficiently distinct from standard ferroptosis biology that a positive result would motivate a new research program at the ferroptosis-evolution interface, attracting both evolutionary biologists and cell death researchers. The translational implication (ACSL4 variants modulating infection susceptibility) also has clinical relevance for immunocompromised patients. |
| Groundedness | 20% | 4 | The Critic assessed groundedness at ~50% with the evolutionary prediction flagged as speculative. Grounded facts include ACSL4's role in ferroptosis (Doll et al. 2017), ExoU phospholipase activity (Sato et al. 2003; PLoS Pathogens 2021), and ACSL4's neurological functions (which the Critic explicitly identified as a verified major confound). The verified neurological data actually counts against the hypothesis by documenting a competing selection pressure orders of magnitude stronger than any infection-driven signal. The balancing selection prediction has zero direct supporting evidence -- no ACSL4 genomic analysis has been performed. Score of 4 reflects grounded peripheral facts combined with a speculative central evolutionary claim and a documented strong confounding selection pressure. |
| **Composite** | | **5.80** | (8x0.20)+(4x0.20)+(9x0.10)+(5x0.20)+(7x0.10)+(4x0.20) = 1.60+0.80+0.90+1.00+0.70+0.80 |

---

### Hypothesis H8: 3-oxo-C12-HSL Directly Inhibits GPX4 via Selenocysteine Modification to Induce Host Ferroptosis

**Critic verdict**: SURVIVES | Revised confidence: 4/10
**Key weakness**: Direct covalent Sec46 modification unlikely (GPX4 catalytic tetrad suppresses selenocysteine nucleophilicity; beta-keto group is too weak an electrophile per published warhead SAR); hypothesis survives via revised indirect mechanism

| Dimension | Weight | Score (1-10) | Justification |
|-----------|--------|-------------|---------------|
| Novelty | 20% | 9 | The Critic found zero papers connecting 3-oxo-C12-HSL to GPX4 inhibition or ferroptosis induction. The 2025 Nature Comms PQS-ferroptosis paper uses a different QS molecule (PQS) and a completely different mechanism (CNMT-TFR1 methylation, not GPX4 inhibition), so it does not reduce novelty here. The re-examination of pre-2012 3-oxo-C12-HSL-induced host cell death literature through a ferroptosis lens is a genuinely novel framing -- those studies predated modern ferroptosis characterization and used no ferroptosis-specific assays (no ferrostatin rescue, no C11-BODIPY, no GPX4 activity measurement). The Critic rated this as LOW hallucination-as-novelty risk, with novelty arising from real conceptual synthesis rather than fabricated facts. |
| Mechanistic Specificity | 20% | 7 | The hypothesis specifies the molecular target (GPX4 Sec46, selenocysteine at position 46), the reaction type (covalent modification), the specific electrophilic warhead (3-oxo/beta-keto group of 3-oxo-C12-HSL), the competing enzyme (PON2 hydrolyzing 3-oxo-C12-HSL at 7.6 umol/min/mg at 10 uM), and alternative indirect mechanisms (ER stress via XBP1/IRE1alpha leading to GSH depletion; PON2-mediated hydrolysis causing cytosol acidification affecting selenocysteine protonation). Even though the Critic showed the direct covalent mechanism is likely wrong (GPX4 warhead SAR in Bioorg Med Chem Lett 2020), the hypothesis is mechanistically rich and names specific molecular actors, kinetic values, and alternative pathways -- unusually high specificity for a cross-field hypothesis. |
| Cross-field Distance | 10% | 8 | P. aeruginosa QS biochemistry and ferroptosis cell biology are separate disciplines, though both touch infection biology. The specific mechanistic bridge -- a bacterial QS signaling molecule (3-oxo-C12-HSL) directly targeting a mammalian selenoprotein antioxidant enzyme (GPX4) via covalent chemistry -- spans QS biochemistry, covalent chemical biology, and ferroptosis cell death biology in a combination that no existing research group addresses jointly. |
| Testability | 20% | 9 | The Critic rated this as passing the falsifiability test strongly and listed extremely precise experimental predictions: (1) recombinant GPX4 + 3-oxo-C12-HSL in vitro activity assay -- completable in days; (2) mass spectrometry for Sec46 adduct -- standard proteomics; (3) cellular ferrostatin-1 rescue assay to distinguish ferroptosis from apoptosis/necroptosis -- feasible in 2-4 weeks. Each prediction can definitively confirm or refute the hypothesis without ambiguity. This is the most actionable hypothesis in the set: a single biochemist with access to recombinant GPX4 and LC-MS could resolve the direct mechanism question in under a month. |
| Impact | 10% | 8 | If 3-oxo-C12-HSL induces ferroptosis (via direct or indirect mechanism), this would reclassify the cell death mode induced by a well-studied immunomodulatory bacterial molecule -- revising years of prior mechanistic literature that classified the death as apoptosis. It would establish a direct molecular bridge from a specific QS signaling molecule to a regulated cell death pathway, with immediate implications for P. aeruginosa pathogenesis in cystic fibrosis lung disease (where 3-oxo-C12-HSL concentrations reach 10-20 uM in sputum). The connection to an active clinical problem elevates translational impact. |
| Groundedness | 20% | 5 | The Critic assessed groundedness at ~65%, the highest of all surviving hypotheses. Independently verified claims include: 3-oxo-C12-HSL biological effects on mammalian cells (multiple studies), GPX4 Sec46 as selenocysteine (verified), RSL3 covalent mechanism (verified), GPX4 warhead SAR showing catalytic tetrad suppresses Sec46 nucleophilicity (Bioorg Med Chem Lett 2020 -- confirmed, and this contradicts the direct covalent mechanism), PON2 hydrolysis kinetics for 3-oxo-C12-HSL (7.6 umol/min/mg at 10 uM, verified). The score is capped at 5 because the specific claimed mechanism (direct Sec46 covalent modification) is contradicted by published SAR data, and the surviving indirect mechanism (ER stress/GSH depletion) is plausible but speculative. The ~65% groundedness from the Critic reflects well-grounded peripheral facts with a contradicted central claim, yielding a score of 5 rather than 6-7. |
| **Composite** | | **7.60** | (9x0.20)+(7x0.20)+(8x0.10)+(9x0.20)+(8x0.10)+(5x0.20) = 1.80+1.40+0.80+1.80+0.80+1.00 |

---

## Final Ranking Table

| Rank | ID | Title (abbreviated) | Novelty (20%) | Mech. Spec. (20%) | Cross-field (10%) | Testability (20%) | Impact (10%) | Groundedness (20%) | Composite | Verdict |
|------|----|--------------------|--------------|------------------|--------------------|-------------------|-------------|-------------------|-----------|---------|
| 1 | H8 | 3-oxo-C12-HSL / GPX4 / Ferroptosis | 9 | 7 | 8 | 9 | 8 | 5 | **7.60** | SURVIVES |
| 2 | H7 | ACSL4 Balancing Selection / QS Iron | 8 | 4 | 9 | 5 | 7 | 4 | **5.80** | WOUNDED |
| 3 | H5 | AHL Lactonases / 4-HNE Cyclic Derivatives | 7 | 3 | 7 | 9 | 5 | 3 | **5.60** | WOUNDED |
| 4 | H1 | 4-HNE / LuxR Solo QS Mimic | 8 | 4 | 8 | 8 | 6 | 3 | **5.50** | WOUNDED |
| 4 | H2 | Ferroptotic Iron Bonanza / QS Threshold | 5 | 5 | 7 | 7 | 6 | 4 | **5.50** | SURVIVES |

*H1 and H2 tied at 5.50. H1 is ranked ahead of H2 on tiebreak by Novelty (8 vs 5), which reflects the Critic's finding that H2's surrounding field is converging rapidly.*

---

## Diversity Check Analysis

With only 5 surviving hypotheses (all 5 are eligible for ranking), the diversity check examines whether any cluster of 3+ hypotheses shares the same bridge mechanism, connects the same subfields, or makes the same type of prediction.

**Pairwise conceptual similarity assessment:**

**H8 vs H1**: Different bridge mechanisms (covalent chemical modification of GPX4 vs structural mimicry of AHL in LuxR pocket). Different directionality (QS molecule attacking host enzyme vs host lipid molecule activating bacterial receptor). Different prediction types (ferroptosis rescue assay vs QS reporter activation assay). NOT redundant.

**H8 vs H2**: Different bridge mechanisms (covalent/indirect GPX4 inhibition by QS molecule vs iron release modulating bacterial QS threshold). Different molecular actors (3-oxo-C12-HSL, GPX4, selenocysteine chemistry vs labile iron pool, Fur regulator, AHL per-cell production). NOT redundant.

**H8 vs H5**: Different bridge mechanisms (covalent chemical biology vs enzyme promiscuity/detoxification). Different directionality (QS molecule acting on host vs bacterial enzyme acting on host lipid product). NOT redundant.

**H8 vs H7**: Completely different type of prediction (biochemical mechanism vs evolutionary population genomic selection signal). No overlap in methods, timescale, or conceptual framing. NOT redundant.

**H1 vs H2**: Both are ferroptosis-to-QS direction. H1 uses structural mimicry of AHLs; H2 uses iron as a shared resource. Different molecules (4-HNE vs labile iron) and different bacterial responses (receptor activation vs QS threshold modulation). PARTIALLY SIMILAR in directionality but mechanistically distinct.

**H1 vs H5**: Both involve host ferroptotic products interacting with bacterial enzyme/receptor systems. H1: 4-HNE as LuxR agonist. H5: 4-HNE cyclization products as lactonase substrates. Both hypotheses feature 4-HNE as the key ferroptotic molecule and bacterial enzymes/receptors as targets. CONVERGENT on 4-HNE-bacteria interaction theme.

**H2 vs H5**: Different molecular bridges (iron vs 4-HNE cyclic derivatives) and different bacterial processes (QS threshold vs enzyme detoxification). NOT redundant.

**H7 vs all others**: H7 is the only evolutionary/population genomics hypothesis. Completely non-redundant in type of prediction and methodology.

**Diversity check verdict**: No cluster of 3+ hypotheses in the top 5 shares the same bridge mechanism, connects the same subfields, or makes the same type of prediction. H1 and H5 show partial convergence on 4-HNE as the key molecule, but their mechanisms are distinct (receptor agonism vs enzyme substrate), their predictions are distinct (binding assay vs activity assay), and they rank 3rd and 4th. No diversity adjustment is required.

The top 5 represent a diverse set of bridge mechanisms:
- H8: covalent/indirect chemical modification (QS molecule --> host selenoprotein)
- H7: evolutionary selection (QS-triggered iron theft --> ACSL4 variant frequency)
- H5: enzyme promiscuity (bacterial quorum-quenching lactonases --> host lipid substrate)
- H1: structural mimicry (host lipid oxidation product --> bacterial receptor agonist)
- H2: shared resource dynamics (ferroptotic iron release --> bacterial QS threshold)

**No diversity adjustments made.** The top 3-5 selection proceeds on composite score order.

---

## Evolution Selection (Post-Diversity-Check)

### Selected for Evolution (Cycle 2): Top 4 hypotheses

| Priority | ID | Composite | Rationale |
|----------|----|-----------|-----------|
| 1 (Primary) | H8 | 7.60 | Clear leader by 1.80 points. Highest novelty, testability, and impact. Despite the contradicted direct mechanism, the broader question (is 3-oxo-C12-HSL-induced death actually ferroptosis?) is genuinely open and the indirect mechanism is chemically plausible. The Critic question for Generator is specific and actionable: propose an indirect mechanism via GSH depletion, iron mobilization, or system Xc- inhibition. |
| 2 | H7 | 5.80 | Highest cross-field distance of all survivors. Evolutionary genomics angle is completely non-redundant with other hypotheses. The Critic's confounding concern (brain function selection >> infection selection) is addressable by focusing the hypothesis on ancient infection pressure and restricting the ACSL4 genomic analysis to variants that do NOT affect brain lipid metabolism. Selected despite WOUNDED status for diversity and evolutionary novelty. |
| 3 | H5 | 5.60 | Highest testability score (9) after H8. The chemical error (tetrahydrofuran vs lactone) is the Evolver's opportunity: the hypothesis can be salvaged by identifying 4-HNE oxidation products that DO form lactone intermediates (e.g., 4-HNE can be further oxidized to 4-oxo-nonenoic acid, which could cyclize via carboxylate to form a gamma-lactone). The Evolver should reframe the substrate as a specific 4-HNE-derived lactone rather than the cyclic ether. |
| 4 | H1 | 5.50 | Tied with H2 but selected over H2 on novelty tiebreak (8 vs 5). The lattice-free LuxR activator problem is the Evolver's target: reframe the hypothesis to require a 4-HNE OXIDATION or CONDENSATION product that retains or mimics a ring structure. The Critic's finding that SdiA activators with ring structures (N-acyl homocysteine thiolactones) work better than non-ring compounds suggests a productive direction: does ferroptotic oxidation of 4-HNE produce any ring-bearing derivative? |

**H2 is NOT selected for evolution** despite SURVIVES status (composite 5.50). The Critic's findings show two of its six load-bearing claims are actively contradicted by 2025 literature, the LIP non-expansion finding directly undermines the premise, and the Fur counter-evidence is mechanistically severe. With only 4 evolution slots, H2 is displaced by H1 (tied composite, higher novelty) and is not advanced.

---

## Cycle Decision Recommendation

Top-3 composite scores: H8 (7.60), H7 (5.80), H5 (5.60). Top-3 average: **6.33**.

Per adaptive cycle rules (early-complete if top-3 >= 7.0): **threshold NOT met** (6.33 < 7.0).
Per adaptive cycle rules (extend if survival < 30%): **NOT triggered** (5/8 = 62.5% survival, well above 30%).
Per adaptive cycle rules (skip Evolver if cycle 2 top-3 >= 6.5): **monitor in cycle 2**.

**Recommendation: Proceed to Evolver for cycle 1 evolution of H8, H7, H5, H1.**

---

*Ranker: Sonnet 4.6 | Timestamp: 2026-03-18T04:30:00Z*
